Bloomberg Kirin Holdings Co. agreed to acquire most of the biochemicals business from its Kyowa Hakko Kirin Co. unit in a transaction valued at 128 billion yen as it seeks to strengthen its budding consumer health-care segment. Kirin is purchasing a 95 percent stake in Kyowa Hakko Bio Co., which produces specialty chemicals and vitamins for the health and wellness ...
Read More »